A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA

[1]  A. Rice,et al.  TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[3]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[4]  O. Bensaude,et al.  Nuclear translocation and carboxyl‐terminal domain phosphorylation of RNA polymerase II delineate the two phases of zygotic gene activation in mammalian embryos , 1997, The EMBO journal.

[5]  K. Jones,et al.  Taking a new TAK on tat transactivation. , 1997, Genes & development.

[6]  J. Karn,et al.  Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type‐1 transcription elongation complex , 1997, The EMBO journal.

[7]  M. J. Mallory,et al.  Stress and developmental regulation of the yeast C‐type cyclin Ume3p (Srb11p/Ssn8p) , 1997, The EMBO journal.

[8]  P. Russell,et al.  pch1 +, a Second Essential C-type Cyclin Gene in Schizosaccharomyces pombe * , 1997, The Journal of Biological Chemistry.

[9]  A. Greenleaf,et al.  Modulation of RNA Polymerase II Elongation Efficiency by C-terminal Heptapeptide Repeat Domain Kinase I* , 1997, The Journal of Biological Chemistry.

[10]  A. Shilatifard,et al.  Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II. , 1997, Current opinion in genetics & development.

[11]  D. Reinberg,et al.  The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme , 1997, Molecular and cellular biology.

[12]  R. Gaynor,et al.  Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes* , 1997, The Journal of Biological Chemistry.

[13]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[14]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[15]  V. Kidd,et al.  Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box. , 1996, Oncogene.

[16]  S. Rogers,et al.  PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.

[17]  A. Rice,et al.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function , 1996, Journal of virology.

[18]  J. Karn,et al.  Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Morgan,et al.  Alternative mechanisms of CAK assembly require an assembly factor or an Activating Kinase , 1995, Cell.

[20]  D. Sterner,et al.  The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex , 1995, Molecular and cellular biology.

[21]  D. Price,et al.  Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.

[22]  R. Young,et al.  A kinase–cyclin pair in the RNA polymerase II holoenzyme , 1995, Nature.

[23]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[24]  Dino Moras,et al.  RNA-Protein Interactions: Diverse modes of recognition , 1995, Current Biology.

[25]  P. Sharp,et al.  Novel mechanism and factor for regulation by HIV‐1 Tat. , 1995, The EMBO journal.

[26]  Nobutoshi Ito,et al.  Crystal structure at 1.92 Å resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin , 1994, Nature.

[27]  J. Pouysségur,et al.  Enhanced phosphorylation of the C‐terminal domain of RNA polymerase II upon serum stimulation of quiescent cells: possible involvement of MAP kinases. , 1994, The EMBO journal.

[28]  B. Peterlin,et al.  Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1 , 1994, Journal of virology.

[29]  David O. Morgan,et al.  A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase , 1994, Cell.

[30]  B. Peterlin,et al.  Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. , 1993, Journal of molecular biology.

[31]  A. Rice,et al.  Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. , 1993, Virology.

[32]  B. Cullen,et al.  Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells , 1993, Journal of virology.

[33]  G. Schochetman,et al.  TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12 , 1993, Journal of virology.

[34]  B. Cullen,et al.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function , 1993, Journal of virology.

[35]  J. Karn,et al.  RNA recognition by the human immunodeficiency virus Tat and Rev proteins. , 1993, Trends in biochemical sciences.

[36]  B. Peterlin,et al.  Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR , 1993, Journal of virology.

[37]  B. Cullen.  Does HIV-1 Tat induce a change in viral initiation rights? , 1993, Cell.

[38]  J. Karn,et al.  High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. , 1993, Journal of molecular biology.

[39]  M. Malim,et al.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. , 1992, Genes & development.

[40]  D. Price,et al.  Control of formation of two distinct classes of RNA polymerase II elongation complexes , 1992, Molecular and cellular biology.

[41]  K. Jones,et al.  Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. , 1991, Genes & Development.

[42]  K. Jones,et al.  A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. , 1991, Genes & development.

[43]  D. Scherly,et al.  A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" protein. , 1991, Nucleic acids research.

[44]  D. Scherly,et al.  The U2B″ RNP motif as a site of protein‐protein interaction. , 1990, The EMBO journal.

[45]  D. Scherly,et al.  Major determinants of the specificity of interaction between small nuclear ribonucleoproteins U1A and U2B" and their cognate RNAs , 1990, Nature.

[46]  D. Reinberg,et al.  News on initiation and elongation of transcription by RNA polymerase II. , 1995, Current Opinion in Cell Biology.

[47]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.